Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-24

FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original ANDA for esomeprazole magnesium as a generic proton pump inhibitor manufactured by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole magnesium (esomeprazole magnesium)

Snippet

ORIG AP for ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)